CSF B-cell expansion in opsoclonus-myocl
β
Michael R. Pranzatelli; Anna L. Travelstead; Elizabeth D. Tate; Tyler J. Allison
π
Article
π
2004
π
John Wiley and Sons
π
English
β 97 KB
## Abstract Lack of a biomarker of disease activity has hindered the therapy of childhood opsoclonusβmyoclonus syndrome (OMS), which is purported to be mediated humorally. To determine if the cerebrospinal fluid (CSF) B lymphocyte, which may traffic into the central nervous system (CNS) to produce